Video

Dr. Duncan on Measuring the Success of Patient Navigation

Mark D. Duncan, MD, from The Johns Hopkins University School of Medicine, discusses demonstrable metrics that help measure the success of a patient navigation program.

Mark D. Duncan, MD, Vice Chair and Associate Professor of Surgery and Oncology, The Johns Hopkins University School of Medicine, discusses demonstrable metrics that help measure the success of a patient navigation program.

Duncan explains that it is very difficult to measure the success of a navigation program based solely on improvements in survival or cure rates. The more demonstrable metrics to measure are those showing improved care, such as pain management scores, comfort, and the timeliness of care.

Since navigators fulfill a series of tasks across the entire cancer care continuum, their efficacy can also be measured through patient education, outreach, screening, diagnosis, staging, treatment, survivorship, and end-of-life care. It has been shown that patient navigator programs can increase both access and utilization of care for poor and underserved individuals. This outreach results in higher cancer screening rates, Duncan notes, which can be measured easily.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | North Carolina
Video

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | North Carolina

May 2nd 2025 - Jun 7th 2025

online-activity
Community Oncology Connections™: Navigating Early-Stage HR+/HER2- Breast Cancer – Clinical Developments and Innovative Treatments | Kansas
Video

Community Oncology Connections™: Navigating Early-Stage HR+/HER2- Breast Cancer – Clinical Developments and Innovative Treatments | Kansas

May 1st 2025 - Jun 6th 2025

online-activity
From Bench to Bedside: Paradigm Shifts in HER2+ Metastatic BTC Treatment
Video

From Bench to Bedside: Paradigm Shifts in HER2+ Metastatic BTC Treatment

May 1st 2025 - May 2nd 2026

online-activity